Brief: DiaMedica Therapeutics Reports Q3 2021 Financial Results
10/11/2021 23:23
Nov 10 (Reuters) - DiaMedica Therapeutics Inc DMAC.O :
* DIAMEDICA THERAPEUTICS PROVIDES A BUSINESS UPDATE AND
ANNOUNCES
THIRD QUARTER 2021 FINANCIAL RESULTS
* DIAMEDICA THERAPEUTICS INC QTRLY LOSS PER SHARE 18 CENTS
Source text for Eikon: ID:nBw8DhRH5a
Further company coverage: DMAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program